Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma
NCT01168752
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
81
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Neoplasms
Solid Tumors
Lymphoma
Interventions
DRUG:
Debio 0932
Sponsor
Debiopharm International SA